Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Seminars in Arthritis and Rheumatism|April 16, 2026
Clinical relevance of specific and non-specific autoantibodies in systemic sclerosis without overlap featuresAndre S Franco, Mateus Cavarzan Lopes, Ana Cristina Medeiros-Ribeiro, et al.
Archives of Rheumatology|May 26, 2023
Patients with inflammatory myopathies overlapping with systemic sclerosis: A Brazilian-Japanese bicentric studyJucier Gonçalves Júnior, Naoki Mugii, Pleiades Tiharu Inaoka, et al.
Rheumatology (Oxford, England)|June 9, 2026
Prospective evaluation of recombinant Herpes zoster vaccine in systemic sclerosis: immunogenicity, safety, and disease outcomesAna Paula Luppino-Assad, Renata P Mello, Ana Cristina Medeiros-Ribeiro, et al.
Arthritis Care & Research|June 15, 2026
Immunogenicity, Safety, and Determinants of Recombinant Zoster Vaccine Response in Idiopathic Inflammatory Myopathies: A Phase 4 Randomized TrialSandra G Pasoto, Thais H B Gorayeb, Ana P Luppino-Assad, et al.
Rheumatology (Oxford, England)|December 11, 2021
SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapyPercival Degrava Sampaio-Barros, Ana Cristina Medeiros-Ribeiro, Ana Paula Luppino-Assad, et al.
Clinics (Sao Paulo, Brazil)|November 4, 2020
Ankylosing spondylitis and psoriatic arthritis: revisiting screening of latent tuberculosis infection and its follow-up during anti-tumor necrosis factor therapy in an endemic areaAndrea Yukie Shimabuco, Ana Cristina de Medeiros-Ribeiro, Renata Miossi, et al.
Rheumatology (Oxford, England)|October 19, 2021
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2Samuel K Shinjo, Fernando H C de Souza, Isabela B P Borges, et al.
Advances in Rheumatology (London, England)|July 10, 2024
2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosisCristiane Kayser, Sandra Maximiano de Oliveira Delgado, Adriana Fontes Zimmermann, et al.
Plos Neglected Tropical Diseases|November 29, 2021
Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseasesAdriana Coracini Tonacio, Tatiana do Nascimento Pedrosa, Eduardo Ferreira Borba, et al.
Nature Communications|October 3, 2022
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patientsClovis A Silva, Ana C Medeiros-Ribeiro, Leonard V K Kupa, et al.
Pageof 3